Emerging Moats, Oscar Health, and Kraken Robotics – with Brett Schaefer

4 Dec 2025 · 1 h 8 min · 20 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

The episode discusses “emerging moats” investing and highlights two off-the-mainstream growth stocks: Kraken Robotics and Oscar Health. Brett Schaefer explains his new paid newsletter/research service (Emerging Moats) that produces periodic company research reports focused on expanding competitive advantages.

Kraken Robotics (Canada/US ADR) makes subsea defense and commercial products, especially polymer-based underwater batteries for unmanned underwater vehicles (UUVs) and underwater imaging/monitoring.

Key claims

the company shifted from losses to profitability and positive free cash flow; it sells into defense contractors (e.g., Angrel/Anduril) with long-term contracts; subsea battery technology is hard to replicate (pressure/electrical challenges). Examples: UUV programs for defense initiatives; CEO Greg Reed’s execution; board addition of Vice Admiral Michael J. Connor. Brett flags premium valuation (high EV/sales; expensive EV/gross profit) and possible dilution, but argues revenue per share growth remains strong.

Oscar Health is an ACA-focused insurer for individual payers (not large employers).

Key claims

modern cloud-based tech and customizable plans create an “innovator’s dilemma” advantage over legacy insurers with tech debt. Examples: member growth from ~200k (2019) to ~2M (2025). Risks: rising medical loss ratios in 2025; repricing in 2026 (blended premium increase ~28%) to target ~80% medical loss ratio and improved expense ratios.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Introduction to Emerging Moats

0:46 to 0:57

Discussion about the emerging moats concept and its relevance.

“See, less carts go abandoned and more sales go with Shopify and their shop pay button.”

Introduction to Emerging Moats

2:06 to 3:00

Discussion about the emerging moats concept and its relevance.

“They're going to be targeting people that pay individually, such as me or you, that own our workforce of all businesses, right?”

Exploring Oscar Health and Kraken Robotics

3:01 to 4:05

Overview of Oscar Health and Kraken Robotics as interesting investment opportunities.

“Welcome to Investing for Beginners podcast.”

Understanding Emerging Moats

4:06 to 5:50

Detailed explanation of what emerging moats are and their significance.

“So you're telling me that there's companies outside of the AI trade, if you will.”

Kraken Robotics Overview

5:51 to 8:12

In-depth discussion of Kraken Robotics and its market position.

“and we are starting a professional stock research service.”

Kraken Robotics Products and Technology

8:13 to 10:00

Detailed examination of Kraken's products and technology for underwater applications.

“So this is a company that, frankly, before you wrote about it, I had never heard of.”

Contracts and Revenue Predictability

10:01 to 14:00

Discussion on the predictability of revenue through contracts in the defense industry.

“And that's what gets me interested in the company.”

Exploring Kraken Robotics' Contracts and Revenue Potential

14:00 to 17:08

Learn about Kraken Robotics' contracts, revenue predictions, and projections for future growth.

“The specific numbers I don't have in front of me, but for example, they do have a big contract with Andruil for, okay, what is it called?”

Financial Health and Share Dilution Concerns

17:08 to 19:38

Understand Kraken's financial performance, share dilution, and future profitability outlook.

“2024, they made$14 million in operating income.”

The Importance of Operating Leverage and Management Frugality

19:38 to 24:14

Discover how operating leverage and frugal management can impact Kraken's future success.

“UUVs or underwater unmanned vehicles are at the same point that on land drones were a decade ago.”
Show all 20 chapters

Customer Concentration Risks in Defense Spending

25:21 to 28:00

Examine the potential risks of customer concentration in defense contracts for Kraken Robotics.

“Simulated trading tools for informational purposes only.”

Kraken Robotics: Management and Valuation Insights

28:00 to 36:02

Discussion about Kraken Robotics' management, performance, and market valuation.

“You mentioned the frugality that you learned from talking to investor relations.”

Oscar Health: Challenges and Innovations

36:02 to 42:08

Exploration of Oscar Health's business model, market challenges, and innovative solutions.

“Let's segue into something completely different.”

Oscar Health's Individual Market Strategy

42:08 to 44:28

Learn about Oscar Health's approach to shifting from employer-based to individual health insurance.

“You just kind of go on these broad-based systems.”

Analyzing Medical Loss Ratio and Profitability

44:28 to 48:17

Understand the implications of medical loss ratios on insurance profitability and Oscar's future.

“but that's going to give up that short-term profitability and it's something that they may not want to risk.”

Impact of ACA Subsidy Changes on Oscar Health

51:34 to 56:00

Explore the potential effects of ACA subsidy changes on Oscar's market position and profitability.

“world at all if these ACA extended subsidies go away.”

Understanding Oscar Health's Emerging Moat

56:00 to 58:11

Explore how Oscar Health is adapting and the importance of scale in insurance.

“Insurance industry will figure out a way to adapt.”

Market Position and Competitors of Oscar Health

58:11 to 1:02:06

Identify Oscar Health's competitors and the competitive landscape in health insurance.

“Is United Health a competitor or are they playing a different game?”

Valuation and Risk Analysis of Oscar Health

1:02:06 to 1:04:20

Discuss the current stock valuation, risks, and potential upside for Oscar Health.

“I was a little biased before I read your report because of all the bullishness, shall we say?”

The Importance of Research Services for Investors

1:04:20 to 1:07:41

Learn about the benefits of utilizing research services for individual investors.

“which is kind of an upstart Mediterranean-style food chain that has a similar model to Chipotle.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00The other night I'm online shopping for Printer Inc. Yes, I still use a printer, I know. And I'm getting ready to check out when I suddenly realize, yet again, I cannot remember my stupid password. But that's when I noticed they've recently added, at the top of the screen, that purple Shop Pay button. One click, and my name, done. Address, done. Card info, done. Checkout, done. Honestly, it's one of the best things in online shopping right now. That button is Shopify. And if you're running an online business or thinking of starting one, Shopify makes the transaction just as easy on your side. They give you inventory tracking, payment processing, analytics, marketing, and much, much more all in one place.

0:38No jumping between platforms, no chaos. And if you get stuck, they have 24 hour support that genuinely is the best. See, less carts go abandoned and more sales go with Shopify and their shop pay button. Sign up for your$1 per month trial at shopify.com slash beginners. Go to shopify.com slash beginners. That's shopify.com slash beginners. This show is sponsored by Liquid IV. Summer is here and let me tell you I could not be more excited from running down to the lake for an early morning fishing trip before work or running my favorite trails or even yard work you name it I just love being outdoors when he heats up but with that heat comes dehydration and sometimes I feel like water just doesn't cut it.

1:23That's exactly why started throwing liquid iv's hydration multiplier sugar-free in my bag every day one stick 16 ounces of water and you're hydrating faster than water alone and the best part is it holds up to four hours powered by their liv hydroscience formula with electrolytes and essential vitamins science backed clinically researched and honestly you can just feel it working currently white peach and rainbow sherbet are my favorites you just tear them open you pour them in simple as that you're done get moving with superior hydration from liquid iv tear pour live more go to liquidiv.com and get 20 off your first purchase with code investing and checkout that's 20 off your first purchase with code investing at liquidiv.com oscar held is an upstart health insurance company that targets the obamacare market and individual payer markets so they're not going to be targeting large um like the legacy health insurance players are they're not going to be targeting large employers to try to get a bundled insurance offering to them.

2:27They're going to be targeting people that pay individually, such as me or you, that own our workforce of all businesses, right? I guess I'm saying... I love this podcast because it crushes your dreams of getting rich quick. They actually got me into reading stats for anything. You're tuned in to the Investing for Beginners podcast. Led by Andrew Sather and Dave Ahern. Step-by-step premium investing guidance for beginners. Your path to financial freedom starts now. Starts now. All right, folks. Welcome to Investing for Beginners podcast. Today, we have our good friend Brett Schaefer back to talk to us about stock market and stocks.

3:11And he also has an exciting new announcement. He has started something new, and we wanted to kind of showcase that and focus on that for today. So, Brett, welcome back to the show, and let's talk about emerging moats. Excited to be here, Dave. Yeah, excited to talk about emerging moats, some other stuff we're doing at the Chit Chat Stocks feed and newsletter, and excited to talk about two different companies. I guess I might be spoiling your little tease here, Oscar Health and Kraken Robotics, robotics companies that I've written about, talked about on the podcast, and think are two very interesting companies growing quickly, have some emerging moat characteristics, and are just overall interesting stocks to follow that might not be in the, which I think some people might be getting tired about, the AI talk, the technology stocks, some stuff off the beaten path that could be interesting for listeners to look at.

4:08For sure. So you're telling me that there's companies outside of the AI trade, if you will. Yes, there are. Really? I did not know that. That's crazy. Yeah. These are companies that may not be talked about on CNBC every day, but that is where I think a lot of the opportunities can lie. And for listeners, I guess, I know you guys are the Investing for Beginners podcast, so there's people that may be just getting started out here. Just because something is talked about on CNBC, Bloomberg, all the financial media, what have you, that just means it's extremely popular. And if you're going to make the money in the stock market, you want to be investing in stuff.

4:53It's not the end of the world if you invest in stuff that's popular, but all else equal. I think it's better to invest in something either that is never going to get popular and stays under the radar forever, or you invest in something before it gets popular. Because if it becomes a crowded trade, nine times out of 10, a lot of future growth can be priced in and the stock might be fairly expensive. Exactly. So before we start really kind of digging into both those companies, I want to talk about emerging moats a little bit. So I guess tell us what that is all about and why the name and if this is going to be any different than Chit Chat Stocks, which you guys currently do with the podcast, for example.

5:38Right. So Chit Chat Stocks is the podcast. That is not chaining for anyone that listens to that. We've talked about that in the show where we still do two episodes a week. We cover a lot of stocks that we're interested in. And Emerging Motes is what we rebranded the Chit Chat Stocks newsletter to. and we are starting a professional stock research service. It is, as the name implies, looking at stocks with emerging moat characteristics. So companies, such as the ones we're going to talk about today, that have characteristics in their business, either because they're growing, either because of their evolving business model, or just how we're looking at them, that has an expanding competitive advantage, or we're trying to at least find stocks that have expanding competitive advantages, and what the service is and it's catered to maybe more advanced diy investors or professional teams but it's a paid research service with some occasional free articles that are going to be tossed into the mix covering every four weeks a full research report on a company such as oscar health or kraken robotics and for anyone that's interested in the type of report those uh i've written about earlier this year and they'll be complimentary and they're kind of the sample reports that people can look at and then every three weeks or not every three weeks for the three weeks each week in between the research reports i'll be doing covering stocks in my uh existing portfolio stuff that i cover or either own or is on my watch list for emerging modes and yeah i mean And it's, I think, hopefully going to have basically condensing hours and hours of research each month into a single research report that readers can look at and read.

7:26Maybe 15 to 20 minute length, not an onerously long report, but also something that's going to have all the information to help get you up to speed on a stock. And I'd recommend anyone checking it out. You can always subscribe to the free newsletter tier. They can give you some previews and the occasional free articles. and if it's something that you like, if you're a moat investor, if you like investing in competitive advantage stocks, then I'd say check it out. I will say that Brett is one of my favorite writers on the internet and he's really good, very thorough and very reasoned and well thought out and I'm looking forward to what he's going to produce in the future.

8:07So I think the world is his oyster. I'm just going to enjoy watching it grow. So let's talk about Kraken Robotics. So this is a company that, frankly, before you wrote about it, I had never heard of. The only Kraken I had ever heard of was related to crypto, and this is decidedly not that. So maybe we could talk about Kraken Robotics. What do they do? Who are they? What do they do? Yeah, Kraken Robotics, I should say, I don't have the exact listener, but some listener of the podcast recommended we look at them. It's a company that is from Canada, but I guess it's kind of a Canadian and United States company.

8:49They are going to report in Canadian dollars, and their main listing is in Canada, but they have an ADR or a listing in the United States for our United States listeners that you can easily buy. They essentially do defense and commercial products for subsea technology. So this can include batteries for electric underwater vehicles. This can include imaging services for underwater stuff or monitoring, let's say, some defense port or something, you know, for the United States Navy. And then when we're looking at them, they are essentially selling this product, either underwater batteries or these imaging services to defense contractors or commercial services, and they'll have long-term contracts with, for example, a company like Angrel or other defense contractors, and they can be considered a subcontractor for this service.

9:47And the reason I like this company is, one, well, if you look at their execution, their historical growth rate has been fantastic. They flipped from losing money to now making money and generating positive free cash flow. And there should be, given what the United States Defense Department, well, I guess it's now changed to the Department of War, but just say the United States military and its allies are investing in and planning to invest in when it comes to underwater autonomous technology, they should be a big beneficiary. And that's what gets me interested in the company. Now today, I think the stock it's definitely at a premium valuation we may talk about that later so it's not one that I bought after doing a research report on them and I think Dave anyone can look up the report I made on them it's completely free if you want a full look at the business but it's one that I would love to own at the right price and I have it on my watch list for now but fascinating business fast grower in a very dynamic industry and i think one that is an underrated way to play kind of the defense spending super cycle that we're in the middle of as we sit here in 2025 it's awesome so a question that kind of pops to my mind is you you mentioned like uh subsea um technology so when i think of that I instantly think of submarines.

11:18Is this what they're doing? Like, are the batteries are they making? Are they making that for the submarines for the United States? Or is there another purpose that I'm not thinking of? So that would be, on a broader sense, yes. But not for, say, the existing submarines that United States Navy has, those nuclear-powered ones, the ones that are just gigantic and have um maybe allegedly i guess they never disclose all the the nuclear warheads on them and there's a ton of spending around that but specifically for kraken they make electric batteries that work in extreme subsea temperatures or sorry not temperatures depths and i i guess probably temperature is part of it as well and they have this specific polymer-based technology that no one has been able to copy.

12:09And unlike, say, an electric vehicle battery or something that's operating on land, not underwater, there are much more technical things that need to happen. One, dealing with the subsea pressure. Two, dealing with the fact that you're going to be operating an electrical system underwater. So it takes a lot more to do that. But what they're specifically selling into and what companies such as Andruil and a lot of the other legacy defense contractors are building are these new initiatives for unmanned underwater vehicles or UUVs, which are similar to the drone technology that a lot of the defense contractors are building for.

12:51So in the future, now they're not building giant ones yet, but that'll be coming down the line. They're building smaller unmanned underwater vehicles for monitoring the oceans and i'm guessing specifically putting you know weapons on there eventually for defense capabilities but they sell into those contracts which is a growing part of the industry but the legacy players or the legacy systems they're not doing that at all that makes a lot of sense so what little i know about the defense industry and and the people that work in the companies that work in the industry, they do a lot on contracts.

13:32And I'm guessing that Kraken has longer-term contracts, and does this make them, I guess, stickier than maybe competitors or other types of businesses? So I guess a better way of asking it, would the revenue be a little more predictable? Would that be a fair question to ask? In some sense, yes, it can be more predictable once they have these long-term contracts in play. The specific numbers I don't have in front of me, but for example, they do have a big contract with Andruil for, okay, what is it called? They have a specific product that they're building as an unmanned underwater vehicle for, I think first actually the Australian Navy, but they're working on getting contracts with the United States Navy.

14:20So that is durable, but given the fact that when their end defense contract customers are maybe not building on a consistent basis or they're selling their batteries on an inconsistent basis they're not going to have steady subscription like revenue from these batteries but they can have predictable contracts and predictable backlog and if you talk to management or if you read their conference calls you can see that all right if we look at their numbers here over the last 12 months, they've done 90 million Canadian dollars in revenue. They talk about a potential, this isn't a contracted backlog, but this is, okay, Boeing, Northrop Grumman, Andrew are all working on these UUV systems.

15:07There's potential for $2 billion in contracts coming down the line for these type of systems that they could hopefully sign and then turn into, all right, well, let's say just hypothetically Andruel's making 50 of these UUVs every year and maybe another company is building a larger one or trying to develop a larger one. And that can turn into, I think, reliable contract revenue, similar to other defense contractors as they get locked into these contracts with the United States Navy and their allies. that's that's definitely a bullish bullish thing for them so um the you mentioned that uh in your kind of intro to the company that they have recently turned profitable has is the company in the in the state where they can maybe are they diluting and in other words are they offering equity to raise money or are they kind of moving past that i know that when looking at Uber recently, that was one of the things I noticed was that they were still offering equity and diluting shareholders to a certain extent.

16:17And is Kraken kind of moving past that? So I wouldn't say that I'm 100 % confident that they move past that. They may be eventually acquiring some other capabilities and they have acquired their way. They actually acquired their way into this, which isn't their entire business, but the promising uh high growth battery segment that had acquired that a few years ago but you are right that in in 20 basically we can say from 2020 through 2024 they were raising a ton of money to increase their manufacturing capacity get up to you know they got to build all this stuff and in ahead of when they're selling it to these defense contractors but if we look at okay 2023 they made$9 million in operating income.

17:092024, they made$14 million in operating income. The last 12 months, they made$9 million in operating income. And their operating margin has grown to 10 % or higher for the last three years or so. And if we go to the cash flow statement, I think it's going to be perhaps a little bit lumpier. But if you look at free cash flow, it's flipped from negative to positive in 2023. But over the last 12 months, it has been negative. In 2024, it was negative because they're three, I think it's about three or four X-ing their manufacturing capacity for batteries to get well ahead of existing demand. I think they will, after this, they'll have the capability to sell about$200 million worth of batteries from these facilities.

17:59So they have some upfront capital expenditures they've recently done. And that's, I think, related to the capital raises they did over the last few years, along with them getting to that operating leverage. But once we go to 2026 and 2027, I think that'll get lapped and they'll have the ability to be self-funding. So I wouldn't worry for anyone researching this company. Something that you probably would get concerned about is looking at that shares outstanding chart. It's grown quite a bit. And you might be worried about that over the next few years and how that could impact shareholder returns.

18:36But I think they'll have the capability to be more self-funding. The share dilution will be a little bit less, although I'm sure they're going to give out stock options to the executive team and employees and what have you. But despite that, if we look at their revenue per share growth, and I'll pull it up on our friends at Fiscal AI right now, Now, their revenue per share has still grown at a 31 % annual rate from 2015 to today. So that's a decade of 31 % revenue per share growth, despite a lot of dilution, which shows, I think, that the company was smart in using its stock price to help fund its growth.

19:15And it's worked out quite well for them. sometimes you got to build up the war chest to invest so that you can grow in the future so yeah you know dilution is always not ideal but sometimes there is rationale for it and the future will tell if that was a good capital allocation or not i agree i agree and i think given the opportunity in front of them given what i think is at least to decade-long tailwind in investing in the uv space there is it's going to work out quite well for them an analogy they like to give and i think this is definitely correct if you look at and i mentioned andrew just because of the most i'd say press release happy fastest growing defense contractor out there they say that if you look at drones a decade ago where that was okay the future of, you know, on land battle or on land warfare, as we've seen in the Ukraine war and other stuff out there.

20:19UUVs or underwater unmanned vehicles are at the same point that on land drones were a decade ago. And that just gives them a massive runway to grow as the militaries, which operate slowly, kind of slowly move those gears and say, OK, this is the future of underwater capabilities. We need to invest in this to be modern and stay ahead of the competition. Yeah. Yeah, that's awesome. So do you feel like you mentioned in the report that you feel like the company could start exhibiting some signs of operating leverage? Do you still feel like that today? I know that you said that the margins have more recently turned positive.

21:03And on an operating income basis, the company is definitely profitable. How do you see that going forward, especially with the investments that they're making today? Okay, for context for the listeners, they have gross margins, and this is over the last 12 months, of 54%. This is expanding a little bit. And the reason I mention that is because, okay, that is the revenue minus the cost of goods sold. So that's the margin they are earning from, all right, we have to build these batteries, or they have other stuff out there. they have the sonar capabilities for underwater imaging systems they are able to sell that with a 54 margin and given the fact that when you're selling into defense or enterprise systems and you have some of the only capabilities out there your marketing sales budget does not have to be very large and if we go from that 54 on the dollar down to what their potential bottom line could be right now of course since they're a smaller company their general overhead costs can be fairly sizable but they also have a large r &d budget and i think both of those as a percentage of revenue will i think not easily but has the potential to be to decline as a percentage of revenue over the next five to ten years because their existing battery technology of course they're working on future systems to try to keep improving this but right now if they're selling again this is just a ballpark number this is not exactly what they're selling eg if they're selling 50 million dollars of batteries of the same technology now if that grows to 200 million 300 million over the next five years and they have the same margin well you're gonna have the similar r &d uh capital expenditures or manufacturing costs as you did while you were selling 50 million Of course, there's the variable cost, but we're talking about below this gross profit line.

23:05And I think there's no reason why they can't keep expanding to 20%, 25 % margin because the fact that you're not going to need to market, you don't need to be spending on Google AdSpend or something like that. You can have a very efficient business below, say, your gross profit minus your R &D costs. And R &D is going to be the number one cost over the long term. And as long as they can be efficient in their general administrative expenses, which interviewing or talking with their investor relations team, I got a very positive sense on their frugality in the executive department. For example, an anecdote I had is that their CEO, who's actually taken them from a tiny micro cap and maybe even a nano cap to the$1 billion plus market cap they have today, he still flies coach and only stays in, I don't know if it's motels, but it's still very frugal when traveling on the road, which I think is a great indicator that they're not going to overspend on their overhead costs.

24:09and that'll help with that operating leverage over the long term. Yeah, that's awesome. I love that anecdote. It reminds me very much of Mark Leonard, right? Exactly, exactly. It's always a good sign when you, if the CEO is just a frugal aunt traveling on the road, I think that is an underrated indicator on their mentality and what they kind of care about taking care of their stakeholders, which includes shareholders first instead of themselves. I'm excited to share our friends over at the Plink app released a major upgrade featuring a sleek new look, real-time insights, smoother trades, and tools that help you feel more confident with every move.

24:46Here's the bonus I think you'll love. They also released the Dividend Match, where they'll match 25 % of all the dividends you earn up to$250 a year. You can track the match along with estimated dividend payouts all within the income hub on the app. More great features are on the horizon to go along with some of their other user favorites like expert ratings, real-time news insights, and simulated trading. Whether you're just starting out in your investment journey or looking to enhance your knowledge, Plink meets you where you are and helps you grow into the investor you want to be. If you've been curious about trying Plink, now could be the time to make the move.

25:17Head to the link in the show description to download Plink today. Max dividend bonus is$250 per year, payouts made monthly, no opt-in required, other terms apply. Simulated trading tools for informational purposes only. Investing involves risk, including risk of loss. Opinions expressed on this podcast are not necessarily those of Digital Brokerage Services LLC, member FINRA, SIPC. I've been thinking a lot about heart health lately. Not because something felt wrong, but because I got my results back and saw markers I'd never even heard of that were out of range. What caught me off guard is how much can be happening quietly with markers most people have never even had tested.

25:50Here's the thing about feeling healthy. Feeling fine and being fine are not the same thing. Most of us track the basics, maybe cholesterol, maybe blood pressure, and assume that that covers it. But there are markers that paint a much more specific picture of what's going on inside your body. For example, your omega-3 index, because your body can't make those fatty acids, and most people are deficient without even knowing it. And amylase, which reflects how well your pancreas is handling the job it does every single time you eat. These aren't obscure numbers, they're just ones that most standard physicals skip entirely, and they're ones I'm glad I know about thanks to function.

26:20That's why I use function. 160 plus lab tests a year, including the cardiovascular markers that actually tell a more complete story. not a guess not a maybe a real look at where things stand that's why taking your heart health seriously actually looks like i use this and you should too check your health the way i do function provides 160 plus lab tests for one dollar a day and member pricing on mri and ct scans join at functionhealth.com beginners or use gift code beginners 25 for a 25 credit towards your membership what's the best way to get started in the market download my ebook for free at stockmarketpdf.com.

26:55Yeah, yeah, for sure. Because the company operates in the kind of defense spending space, is there any over-reliance on a particular customer or customer concentration that could be a red flag in the future or could cause them problems if that one customer leaves? Yes and no. Of course, if one of these projects just get scrapped uh meaning the uv projects and within that there's the sonar imaging and the basically monitoring with the 3d imaging and just kind of all right well we're gonna do imaging stuff for the military and commercial services that can be a part of these deals but i think positively there's i believe over 10 uv projects in development from defense contractors so they're not over reliant on just one customer such as andrel now andrel is maybe their biggest customer now because they're the one that moves the quickest but when these other defense contractors catch up they'll be in the mix as well and i don't necessarily think that the customer alliance is a risk because they're not selling to the united states defense department they're selling to the defense contractors and they're the only company that has the subsea batteries with the capabilities that can sell into these uvs just at the most efficient cost they're 200 i think the number is at least 100 or 200 more energy efficient and density efficient compared to any competitor out there and of course if the united states military decides to pivot away from unmanned underwater vehicles that would take away some of their demand but i think the likelihood of that is extremely low because when you're operating an underwater vehicle you'd much rather have it be unmanned because it's just really really hard to operate with the person in these summaries and ideally you'd want these type of systems to not have anyone stuck down in a little tube for months on end at all yeah right uh so what are your thoughts on management?

29:13You mentioned the frugality that you learned from talking to investor relations. It's a smaller company, so management feels like it's probably more important than it would be for MasterCard, for example. Not that they're not both important, but it feels like for a smaller company, they definitely are more important. So what are your thoughts on management, their capital allocation skills, how they're approaching how the company can continue to grow and so on. I like what management has done, but of course they are a smaller company that has become a micro cap and developed into a small cap over the last five years or so.

29:53And I'm trying to, his name is escaping me. Okay. Yeah. Yep. I had it right. So the CEO is Greg Reed, who was an ex finance guy. I believe the CFO of the, of the company. And if we look at the reason he transitioned to become the CEO is because the founder of Kraken Robotics unfortunately passed away due to health complications, but he was leading the business and then Reed, Greg Reed, took over and has actually done a phenomenal job. Now, what I'll be interested in looking at is, okay, Reed, he's done a great job, but he hasn't, he hasn't led a business of this size and his only historical just experience within any sort of company leadership is in accounting and finance.

30:40So I wonder if they're going to maybe transition to a more professional defense contract focused CEO over time. But I think so far so good looking at their execution. I mean, you can just see the numbers and the contracts they've won. It has been great. You can't say really anything negative about what Greg Reed has done. And they've added more, let's say, industry-focused leaders on the board of directors. For example, they just added Vice Admiral Michael J. Connor to the board of directors, and he has a huge, long-standing career in the United States Navy. I believe he's retired now. He was, and let me get this right by looking at his bio, He was the vice admiral in the United States Navy of, I think, something within the United States submarine forces, which would relate specifically to the UUV systems.

31:36And he should be a great asset to have on the board of directors to connect Kraken Robotics to the United States Defense Department. Unquestionably, unquestionably. So this sounds like a really, really intriguing business. The next question that I would ask is let's talk valuation. Every company is great, but some are better than others based on where they are with the price. So how do you think about Kraken and valuation? Yeah, and even with the recent drawdown here, the stock is up, and I'm looking at the chart right now, 772 % with, and this is their Canadian listing, the US dollar one is going to be a little bit different just because of foreign exchange.

32:16but 772 percent in the last five years if we look at their canadian market cap it's 1.63 billion dollars and if we bring the enterprise value into play it's not going to be that much different just because they've raised a lot of money through their share offering so we'll get 1.6 billion dollars and they're trailing 12 month revenue is about 90 million canadian so their price to sales ratio or EV to sales is going to be fairly high. And if we look at something such as a top line earnings metric that I like to look at, which is EV to gross profit, which kind of brings down that variable cost and I just think it's better than price to sales when looking at a top line metric.

32:58The trailing one is 33.6, which is quite expensive. But given their growth rate, as we talked about the revenue per share is growing at a 30 % rate over the last 10 years i think it has a chance to keep growing at a similar pace the valuation isn't maybe insane but i i would not uh want to be a buyer here i'm keeping it on the watch list they let's just go through okay they can probably earn conservatively a 20 operating margin at scale i'm not sure exactly i can't remember exactly what i put in the research report but let's say it's something around that if they scaled up to 500 million canadian dollars in revenue that would be 100 million in operating earnings which would be a reasonable price earnings ratio compared to the current market cap of 16 that's 1.6 billion dollars divided by 100 million in operating earnings well to get there they'd have to more than 5x their revenue so it's i think it's an expensive stock but is it a fascinating business it's one i'd love to own at the right price and if we see a downturn in defense stocks because of a narrative around the super cycle, maybe there would be an opportunity to buy, or if there's a down cycle just in stocks in general, we've seen their stock draw down quite quickly with the stock market correction here in November.

34:36If there's an extended drawdown, this is one I love to own because this is not going to be reliant on consumer spending. The great thing about the United States military is that the spending is going to be there if it's a part of their, let's say, systems that they feel is very necessary to keep up defense superiority, which would be the underwater capabilities with the nuclear summaries and all the underwater stuff is a part of that. Now, the downside is that they can move slowly. but I think given the fact that there's not going to be any cyclicality from the end market here, if there's a stock market drawdown and the stock gets very cheap, it's something I would be interested in adding to my portfolio.

35:25It sounds like a really intriguing business and it sounds like management is on top of it and is doing a good job of executing on what they're trying to do and they're not trying to be anything they're not. And I think that's also appealing as well. Yep. And the last thing I'll add is that this is a potential acquisition target of a company such as Andrel because that could give them proprietary technology for the UV development. So something to keep something definitely to keep an eye on. Yeah, I loved learning about this company. It was kind of fun. All right. Let's segue into something completely different.

Read the full transcript

36:06and let's talk about Oscar Health. So this is another company that you wrote up that will give people an example of what is coming with emerging moats. So who is Oscar Health? What do they do? And what is their main business model? Okay, and full disclosure, I do own shares of this company today, I guess, unfortunately, given how the narrative has played in recent months with the Obamacare slash Affordable Care Act. subsidy stuff that's happened politically but oscar held is an upstart health insurance company that targets the obamacare market and individual payer markets so they're not going to be targeting large um like the legacy health insurance players are they're not going to be targeting large employers to try to get a bundled insurance offering to them they're going to be targeting people that pay individually with such as me or you that own our workforce small businesses right i i guess i'm saying quickly if you you are someone that has to pay for your health insurance yourself yes so you know the pain of the aca market and oscar held is trying and i think is successfully building a better solution for customers so given the fact that they built a modern cloud-based tech digital system.

37:28I'm not going to pretend to be an expert on software here, but it's software that works much better than the competition. And they're trying to, I think, are executing on building a much more customizable plans for individuals that are paying into these systems. And it's just a, as they pitch it, a better way to buy health insurance. Instead of having limited options you can have varying plans for your specific needs and the fact that they have they don't have the tech deck of the competition they could do it at a cheaper price more efficiently and i think the the proof really is in their scaling up of customers because i think from and let me get the year right in 20 yeah 2019 they had 200 000 members which would be paying people on their insurance plans.

38:20Over the last 12 months, they've had over 2 million, or just, yeah, this year in 2025, they have about 2 million. Now, there's some things holding up the stock, and there are things that if you are someone that follows maybe UnitedHealthcare or some of these larger players out there, Oscar Held is facing the same headwinds in 2025 that's hitting the entire health insurance market. But I do think these are temporary headwinds that they can reprice for 2026 and i'm happy to go through all the details on that but i think it's an interesting company one that given if we want to talk emerging moats given their increasing scale in the industry and the fact that they had the innovators dilemma at their back where if you look at the again legacy players with all the tech debt as people well know it's very very hard to deal with those companies.

39:11If someone can build a modern solution that actually is maybe not enjoyable, because I don't think anyone enjoys dealing with the health insurance system or enjoys dealing with healthcare in general, but one that is not going to be as frustrating, time waste, and can actually provide you value instead of feeling like just a total money suck from your bank account. Yeah. And this is appropriate timing because we're recording this in November, and this is when everybody is starting to go through the process of trying to work with the different health insurance providers to get their health insurance for the coming year.

39:52And my wife actually just had the pleasure of going through the website and trying to figure out how to do all that, and it took her and me a few hours to go through it, So it was lots of fun. So my question is, and this may be a dumb question. So is Oscar Health a platform provider? Are they an insurer or are they a broker? Are they kind of something in between all three of those? They are the insurer. They will work with brokers. And I think you might be mandated to work with brokers within the ACA or Obamacare markets where you have the, I think the website is healthplanfinder.org, something like that.

40:33It might be different for different states, but you have to go through different brokers, and then they are, yes, the one that is insuring them. So they care about stuff like medical loss ratio, all that stuff. Premiums earned, they make their revenue by just generating premiums, and it's like any other insurance company where you want to have your loss ratio be as low as possible. Although for Obamacare slash ACA markets, you're actually mandated to have a maximum medical loss ratio of 80%. So that's kind of their target floor for how profitable they can be. But they want to have that as low as possible and just be efficient on spending as possible and gain more members.

41:14Okay. All right. That makes complete sense. So you mentioned the idea of the innovator's dilemma. So I'm curious what you meant by that and how that applies to what Oscar Health is trying to do. I think about it's similar to legacy banks versus modern banks, such as a SoFi and Ally. NewBank, maybe, as I know, is one of your favorite companies. And Dave did come on Chit Chat Stocks recently and talk NewBank if people are interested in more updated thoughts on that company. But I think it's similar in that regard where you have, again, these health insurers that have been around for decades that have outdated technology, have this technical debt, not physically sitting on their balance sheet.

41:59It's not going to be there accounting wise, but it's going to hold them back as they try to modernize and make systems that just work for customers. oscar is starting from scratch they're building stuff that they hopefully can just make it easier to work with from your smartphone from everywhere for for these customers and they want to go to these individual payers convince them to sign up and then go oh this is much better than what i've been doing in the past and i think that's really what the innovators dilemma is here it's not maybe people that are very i don't know if they like the innovators dilemma a lot maybe it's not classically that because it's not a business model shift but you could argue that the employer versus individual payer market is an innovator's dilemma because when you have the large employer-based system where you could be a company of 10 000 20 000 people and you're offered three different health plans.

43:04You just kind of go on these broad-based systems. It's very, very, very inefficient. And the best way I think, and where the incentives really align with all the stakeholders in the ecosystem is the individual market where even if a company is providing or paying for your health insurance, they allow you to go to, and they call this ICHRA. I forget exactly what the acronym stands for, but essentially what it means is that even if your employer is providing health insurance for you, they are just giving you, say, a credit or giving you money, part of your salary, to specifically pay for health insurance on the individual market.

43:47And that allows you to go out to, you know, maybe not just OSCAR, but all the different health insurance providers on the Affordable Care Act marketplace to find something that actually fits specifically for you and that's just a much better system but these legacy players want to use the employer system because they can bundle get tons of people on that and it might not be better for the actual individual but it's more profitable for them and if they were going the innovative dilemma is if they want to kind of catch up with oscar health and this is something i think will develop over the next five or ten years they're going to have to sacrifice near-term profits and sacrifice near-term members by saying, all right, we need to go after this individual space, but that's going to give up that short-term profitability and it's something that they may not want to risk.

44:39So a question that pops to mind is something you mentioned a moment ago about the loss ratio and they're kind of capping the floor at 80%. That to me instantly smells like they're putting a limit on how much profit a company can make. Government mandates. Yeah. Yeah. So that gives me the heebie-jeebies. So how can I move past the heebie-jeebies? Like, am I wrong? Or is that a limiting factor in this company? It's a limiting factor, but I think maybe to get past it, you could look at UnitedHealth's stock price because it's done quite well over the last, especially since Obamacare has been enacted.

45:23And I think the key thing to look at is, one, the medical loss ratio. And right now, they are seeing, in 2025, along with a lot of health insurers, they're seeing rising medical loss ratios where last quarter we were at, I believe, and let me just add a decimal to this chart so I can get the exact figure, 88.5 % versus the year ago period at 84.6%. And that has impacted their ability to generate a bottom line profit this year. so they're going to lose money in 2025 but that's because just given morbidity stuff just given health care utilization the actual costs that are being put onto them are higher than they expected and are higher than most health insurers expected in 2025 now they're going to reprice in 2026 and actually said their blended price increase which you probably won't like and i'm not going to like it as an individual payer is going to go up by 28 in 2026 and that's because they're going to try to reprice to get profit on closer to the 80 % medical loss ratio.

46:27What I think investors need to look at, and yes, of course, if they could be as profitable as possible, that would be great, but it's probably not going to ever work out like that in the healthcare space, just given the way that it's looked at politically and as a society. But what you need to look at is medical loss ratio and then their ratio of essentially operating expenses as a percentage of remedy or percentage of premiums earned where you want that difference to be or if you add medical loss ratio plus their operating expenses ratio you want that to be below 100 percent and what i'm looking at or what i like about oscar else is that their operating expenses as a percentage of revenue keeps declining, which will help them earn a larger and larger profit as that medical loss ratio maybe hopefully more consistently is closer to 80%.

47:26So last quarter was at 17.5%. I want to look up what it was over the last 12 months if I can get that number. I guess I don't have it in front of me, but let's just say that number is trending down and down and down and they can get it over an annual period to 15%. And their medical loss ratio can get close to 80 % per year. So you have 80 % plus 15%, that's 95%. If we do 100, I know this is a lot of math for the listeners, 100 minus 95, that is a 5 % pre-tax profit margin. That is a great target for them, I think is very attainable if they can price consistently profitably. And if 2025 is an anomaly, which given how everyone in the health insurance space is kind of getting blindsided by these rising costs, I think it likely is.

48:22This all reminds me a lot of Buffett's discussion about the pricing and profitability of the insurers that he runs. And the ratio that I'm familiar with is the combined ratio, which looks at the loss ratio and the expense ratio. And yeah, any company that operates under a hundred percent is like, uh, so that, cause those are, those are real profits for those businesses. So, uh, I love that explanation. So, okay. Subsidies are scheduled to go, go off a cliff in 2026. You know, you, You mentioned earlier that you own the company and it's not done well in part probably because of what the market is expecting with this.

49:08How are you looking at this as a shareholder of Oscar and how do you think that this will play out and what would be maybe what would be a good sign and what would be a bad sign if you know depending on how this goes. So here's the deal. Normally when we do these ads the company sends us a script that we have to read word for word. But Perfect Jeans they didn't do that. They shipped me a pair of jeans and said just be honest. That alone tells me how amazing this company actually is. So I'll be honest. I've worn the same brand of jean for as long as I can remember. After one day in these, I'm switching.

49:40Done. They're that comfortable. Sitting, driving, grilling, golfing, traveling all day. No issue. They come in six different fits from skinny all the way up to that thick thick with over 5 ,000 size combinations. So you'll actually find the proper fit. Now here's the best part. My usual jeans run about$220, and that's pretty on par for most premium jeans. These,$80. That's it. Same premium construction, half the price. Genuinely, no-brainer. Our listeners get 15 % off their first order plus free shipping at theperfectjean.nyc. That's theperfectjean.nyc, or just Google theperfectjean. and use code INVESTING15, that's INVESTING15, all caps, at checkout for 15 % off today.

50:26The first time I heard about Bitcoin, honestly, I thought it was a scam. I did not realize it was something that would last, and I was wrong. Technology has made it so much easier to use these days, especially on Cash App. With Cash App, it was so easy for me to take the direct deposit I already receive, allocate a percent of that to automatically buy Bitcoin inside of the app, and I can use that as a form of payment in so many places. If you've been curious about Bitcoin but haven't made the jump yet, Cash App makes it easy. You can set up automatic purchases with zero fees or buy larger amounts also with zero fees.

51:02Start small or go bigger. It's designed to be simple either way. For a limited time, new customers can get$10 added to their balance. Just use code CashApp10 when you sign up and don't forget this part, Send at least$5 to a friend in the first two weeks. Terms apply. Cash App is a financial services platform, not a bank. Banking services provided by Cash App's bank partners. Bitcoin services provided by Block Inc. brand. For additional information, see the Bitcoin disclosures at cash.app. slash legal slash podcast. So I'll give a take that some people may disagree with is I don't think it is the end of the world at all if these ACA extended subsidies go away.

51:43Now, context for what this is, during the COVID pandemic, the Biden administration basically extended either through tax credits or just the cost of what premiums would be for people on the ACA marketplace. It just kind of elevated the ceiling of what your income would be to get these ACA subsidies. So instead of, say,$300 a month premium, you can go down to$75 a month if you are below a certain tax bracket. Now, these are set to expire, and there's a whole, I'm not going to say whether I agree or not put it, like, what I would vote on for extending them at all, but it's up in the air, and it looks like the Trump administration does not want them to go through, although there is the, you know, Congress can vote on them, and it's the whole U.S.

52:36political system within this. but it looks like for the time being it's maybe leaning to not get extended into 2026 and the way this would impact oscar health is that it's going to most likely lower their total members for a short period so they as i mentioned 10x their total paying members from 2019 to the last 12 months they'll probably get lowered in 2026 but i don't think that makes them unprofitable by any means. It just means that, okay, we're going to reset at a lower base of the individual payer market. And what's most important to me is the fact that they can reprice and hopefully get that medical loss ratio back closer to 80%.

53:19Because if we look at the company, and I'll just give some numbers here, they are doing a little over$11 billion in revenue. Now, if they increase their premiums by an average rate of 28%, but they lose, say, 10%, 20 % of their members, they'll probably be still doing the same amount of premiums next year. But if they can get, and I'm not saying they will, but if they can get a 5 % operating margin on$11 billion in revenue, that is about$550 million in pre-tax earnings. Well, the market cap today is$3.9 billion. So what matters to me is getting back to profitability and the ACA subsidies, Well, it'd be nice if they stayed around because then we could have a higher total addressable market for Oscar health and individual pair market.

54:09It's not the end of the world. And I think what matters the most is just pricing better in 2026. All right. Yeah, it sounds like that's going to be a very big part of the investment in Oscar health going into the future here, right? Exactly. Exactly. And I'd say taking the bigger picture, if the subsidies go away or not, the individual market is growing. And the long term, maybe called the green shoot bull thesis, where this could be a 10 bagger stock or something along those lines, is the fact that there is a trend of small and midsize businesses. instead of doing these employee sponsored plans which are getting really really expensive for small businesses to offer they are saying and there is just a market share shift over time of them going all right well we're going to do as i mentioned before give the employee money however they do it and having them pay on the individual market and that is a instead of i I think the addressable market for individuals right now is about$20 million.

55:21That addressable market, if you add in these individual employee payment accounts, again, I'm getting the acronyms wrong, but people get what I'm saying, that adds tens of millions of new potential customers to go after. And that whole shift in the industry, as I mentioned earlier with the innovator's dilemma of the employee-sponsored plans, is a huge long-term opportunity for Oscar Wilde. And they're making inroads on this. for the exact company i think it was hyvee in iowa iowa i think that's the grocery chain there they're partnering specifically with them to do uh this type of health insurance plan for their employees and the more momentum they have in that space i just think there is a long long runway to grow and people that are getting hung up on oscar health stock kind of being in a drawdown because of this ACA subsidy overhang, it's not going to be, if we look five years out, this isn't the make-all be-all for this investment.

56:21Yeah. Insurance industry will figure out a way to adapt. They always do. Yep. Yep. So how do you feel about the, what to you, I guess, indicates an emerging moat for this business? That's a good question. I think increasing scale, because in insurance, you really need increasing scale for the business model to work. I mean, they've just, even before 2025, they just flipped and kind of moved from unprofitable to profitable. And a lot of that came with bringing in an experienced CEO who could get some of the stuff that they were wasting money on as kind of a tech startup in the insurance space, kind of get that stuff right sized.

57:05but i think increasing scale is really what matters at the end of the day and the kpi i'm looking at of course i'm looking at medical loss ratio because that is important for the underlying business but growing members and growing scale is is just vital and that may seem simple but as they get higher members they're able to distribute their costs at a lower rate uh you know over a larger base of customers and like any other health insurer out there or any other insurance company in general, the larger scale you have, the better your business can run. And if we look at, you know, Oscar Health was, we'll call them a Zerp era company.

57:44And now that Zerp or zero interest rate policy is over, I think, maybe it'll come back at some point. But now that that's over, and they are the one that's still standing, they're the one that is getting to sizable scale here to become profitable, it would be extremely difficult on the startup end for someone to come in here and try to compete with them so i think on both sides of the table you have the innovators dilemma with the legacy players you have really the walls shut off or the gate closed for a zerbera startup to come in and try to compete with them directly and as they as australia just keeps growing their members that moat i think will emerge and widen over time and that that's really what i'm tracking as an investor who would you who would you say are their competitors?

58:32Is United Health a competitor or are they playing a different game? United Health is a competitor. It's hard for me to remember exactly who was, I think there's a lot of ones out there. There's Centene that does Ambetter. I just remember them because they're actually the ones that I use for my health insurance. I say I would use Oscar Health, but they're not available in my state.

58:57Yeah, there's a lot out there. You can look at any the ones that are into the ACA marketplace or the Obamacare marketplaces. Oscar Health is not available in every state. This stuff is a state-by-state basis. There's a lot of different regulations you have to go through, but yeah, I'd say generally, you know, UnitedHealth, Centene, there's plenty of players out there that are going after this. Now, some health insurers are targeting more employee-based, but at the end of the day, I'd say their competitor is anyone one providing health insurance in the United States. All right, that's fair. So you mentioned several times that the stock is down.

59:37What would be the risk reward slash valuation today? And what do you think that looks like going forward? Yeah, so for context, stocks in a 35 % drawdown from recent highs in actually October. So it's been quite quick within the last year or so. And they IPO'd at a much higher price. I think the stock is at a very attractive price. It's not one I have sized up completely in the portfolio because it, or it's not my largest position just because they're unprofitable right now. And the insurance place is stuff is tough, excuse me. But I think again, at a market cap of$3.9 billion, they do currently have, and I'm using the fiscal AI numbers, so people might calculate a little different on their own.

1:00:26Technically, their enterprise value is 2.5 billion dollars but that's because they have the excess capital on their balance sheet to manage as an insurance company but i think if they start as i talked about earlier getting that pre-tax profit margin up to five percent and they keep growing i see no reason why eventually their premiums can't reach 20 billion dollars 30 billion dollars over the long term and if you have again 20 billion in premium five percent margin that is a one billion dollars in earnings for a company with a market cap below$4 billion. And that is the full scenario. And if it plays out, I think with how profitable an insurance company can be at scale when they start generating that excess capital and returning cash to shareholders, I think there's a chance that this is a 10-banker type investment.

1:01:16There is downside if they can't turn things around from and profitability perspective, but with how the ACA market is priced, they, yeah, look, all the health insurers made a mistake in 2025, but generally they've been able to price, and they all price somewhat similarly, where the differentiation is, again, in Oscar Health's customer experience and not having kind of the headaches with dealing with all the paperwork and stuff like that. They're able to price profitably. They know that they're going to earn a slim margin, but one that could grow consistently. And I just think the downside is overrated and people are looking at a company that is, yes, unprofitable today, but has a clear path just from repricing and resetting this year to getting back to profitability in 2026.

1:02:09Yeah, it's an intriguing company. I was a little biased before I read your report because of all the bullishness, shall we say? Well, it was a popular stock. Yeah, on Fentwit. There was a lot of very enthusiastic investors with the company, shall we say. Yeah, let's say there's a lot of people out there in financial media who, everyone can do their own thing, but when people are touting revenue growth as kind of the end-all, be-all for an insurance company, just know that, yes, Oscar Health has grown revenue quickly, but that's really not what matters for an insurance company. It's how profitable they can be.

1:02:49And yeah, look, we want the premiums to scale up, but what matters is that medical loss ratio. And that's what I'm going to be looking at above all else. Yeah, that's exactly right. Perfect analysis. I would expect no less from you. So I guess as we talk about these two companies, I think they're a great example of the kind of research that you do and the work that you do. Going forward, are you going to continue to search out these kinds of companies? Are smaller cap, micro cap companies the ones that you're going to focus on? Or is it going to be, you're not going to be agnostic. I'll be willing to look at anything.

1:03:32I think I'll be agnostic in the fact that I want to look at stuff that is a potential emerging mode. So for example, I looked up The first research report I released behind the paywall was on gambling.com group, which I think is something that potentially had an emerging moat as I looked at it. And the reason I talk about emerging moats is I don't want to be the 100th report on Alphabet or Apple or what have you. That's just not the game I want to play. So while I'd be looking at the Magnificent Seven stocks, maybe if one makes it into my portfolio, it's kind of one of those weekly updates. but for the full research reports, probably not.

1:04:12For example, if we look at my upcoming, I kind of planned out the schedule for the rest of 2025. The other full research report I'll be doing this year is on Cava Group, which is kind of an upstart Mediterranean-style food chain that has a similar model to Chipotle. But if you look at companies that are either in my portfolio or on my watch list for the rest of the year, I'll be covering stuff such as Sprouts Farmers Market, Remitly Global, the remittance provider, crocs uh grupo omab which is a mexican airport operator oscar held is on the list and then doing a portfolio review so full research reports quarterly updates and stuff that is on my existing watch list or in my portfolio and then doing regular maybe once a quarter i haven't figured out the exact timing on that whether i'm going to be doing it once a year maybe or at a more frequent basis of looking at my portfolio and kind of doing a deep dive into that and more portfolio management stuff.

1:05:11But yeah, that one's coming at the end of the year. That's awesome. I suspect as you go along that some of those things will probably fluctuate a little bit depending on market conditions and things of that nature. So there'll be some flexibility that will be necessary as the market goes up or down. Exactly. Yeah, we don't know what stocks will be cheap in a few years from now, but I hope to cover them. I thought you were the guy that was going to know that. I've been, you know, my crystal ball has been broken for quite some time, and I was hoping you would have all the answers. Yeah, if that were the case, I would be on a beach somewhere and worth a lot more money than I am right now.

1:05:51Yeah, you wouldn't be talking to me. Yeah. That's awesome. So anything else about emerging moats that you think is pertinent or relevant to people that are considering the service or are interested in what it is that you're doing? uh the final thing i'd say is look some people may not have the propensity the want or the budget given if they're smaller and smaller time investor to pay but i'd say just hop on the free tier for the time being um and listen to the podcast listen to the investing for beginners podcast as well try to keep learning and if you uh are just building out your portfolio over time you become a larger investor it makes more sense if you are someone that invests in individual stocks on your own to pay for various research services that can help you with your research it's something that i think is underrated and has become more democratized as the newsletter services have expanded over the last five to ten years something can be very affordable and if you look at it as just as okay if you're doing investing as yourself you don't have a financial advisor if you're a financial like if you say you had a million dollar portfolio and you had a financial advisor and they charge one percent per year that's a quote-unquote ten thousand dollar budget for your portfolio every year that you're outsourcing to your advisor if you are looking at individual research services, you can spend significantly less than that to have people do analyst work for you to help you with your portfolio.

1:07:32And I think that is the sweet spot, along with professional teams, that emerging moats research, that's the target audience that we're trying to look at. Yeah, I would agree with that. I think the amount of knowledge and insight that you can get from other people's points of view, especially smart people like Brett, can be very, very valuable and can make you a lot of money just by having one good idea that you get from somebody can be very, very profitable. And it's super, super helpful because investing tends to be a solitary game. And when you have somebody else, i.e. like Brad, to help you along the way, that can be hugely beneficial.

1:08:17Couldn't have said it better myself, Dave. Thank you. Thank you for the pitch for You're welcome. But you know, I believe all those things and I've been saying this for a long time. And I think the more that you can align yourself with smart people, the better you're going to be. And it's always, you know, it's always, I've always felt like it's best. It's always best to not be the smartest person in the room. And so when you, when you approach things like that, then you can learn from other people. And there's plenty of smart people out there and Brett's definitely one of them. So I appreciate you taking the time to come talk to us today.

1:08:51And of course, I will put all the show notes, all the links in the show notes, including to the two stock research reports as well, a link to Emerging Motes. And with that, we will go ahead and sign us off. I appreciate you, Brett, again, for taking time to come talk to us today. Thank you, Dave. Yeah, thank you for letting me talk Emerging Motes, Oscar Health, Kraken Robotics. and I hope listeners learned something from this interview. I'm sure they did. Well, with that, we'll go ahead and sign us off. You guys go out there and invest with the margin of safety. Emphasis on the safety. Have a great week and we'll talk to you all next week.

1:09:29We hope you enjoyed this content. Seven Steps to Understanding the Stock Market shows you precisely how to break down the numbers in an engaging and readable way with real life examples. Get access today. at stockmarketpdf.com. Until next time, have a prosperous day. The information contained is for general information and educational purposes only. It is not intended for a substitute for legal, commercial, and or financial advice from a licensed professional. Review our full disclaimer at einvestingforbeginners.com. The right window treatments change everything. Your sleep, your privacy, the way every room looks and feels.

1:10:16At Blinds.com, we've spent 30 years making it surprisingly simple to get exactly what your home needs. We've covered over 25 million windows and have 50 ,000 five-star reviews to prove we deliver. Whether you DIY it or want a pro to handle everything from measure to install, we have you covered. Real design professionals, free samples, zero pressure. Right now, get up to 45 % off site-wide, plus get a free professional measure at Blinds.com. Rules and restrictions apply. Ryan Reynolds here from Mint Mobile. I don't know if you knew this, but anyone can get the same premium wireless for$15 a month plan that I've been enjoying.

1:10:49It's not just for celebrities. So do like I did and have one of your assistant's assistants switch you to Mint Mobile today. I'm told it's super easy to do at mintmobile.com slash switch. Upfront payment of$45 for three month plan equivalent to$15 per month required. Intro rate first three months only. Then full price plan options available. Taxes and fees extra. Default terms at mintmobile.com.

From the publisher

Want to go deeper on real companies with simple, long-term investing guidance? Subscribe to the Value Spotlight newsletter, where Dave and Andrew share stock ideas, valuations, and lessons from real businesses straight to your inbox.

In this episode, Dave and Andrew welcome Brett Schaefer to talk about “emerging moats” and showcase his new research service. 

Brett breaks down why he’s focusing on companies with growing competitive advantages, and shares deep dives into two off-the-beaten-path stocks: Oscar Health and Kraken Robotics. 

The conversation covers what makes these businesses unique, the risks and rewards, and how investors can spot the next wave of winners outside the usual tech hype.

Key Topics Covered: 

What is an “emerging moat” and why it matters 

Kraken Robotics: defense tech, contracts, and growth runway 

Oscar Health: ACA market, tech disruption, and scaling up 

The risk and reward of dilution, contracts, and regulation 

How to spot scalable competitive advantages 

What Brett looks for in small/mid-cap stocks 

The long-term opportunity in individual health insurance

Timestamps: 

00:00 Intro and Brett’s new research service 

03:00 What are emerging moats and why focus on them? 

07:00 Kraken Robotics: tech, contracts, and defense industry growth 

13:00 Oscar Health: ACA, tech, and the innovator’s dilemma 

26:00 Risk, reward, and scaling up 

40:00 How Brett researches and what’s next for Emerging Motes 50:00 Wrapping up and links to research

Resources Mentioned:

The Value Spotlight Newsletter:  https://einvestingforbeginners.com/value-spotlight-newsletter/

Emerging Motes Newsletter & Research:  https://www.emergingmoats.com/

Chit Chat Stocks Podcast: 

https://podcasts.apple.com/us/podcast/chit-chat-stocks/id1437766060

Have questions or want your story featured? Email the show at newsletter@einvestingforbeginners.com or comment below. Your feedback shapes the podcast!

Remember, invest with a margin of safety—emphasis on the safety. Have a great week, and we’ll talk to you next time.

Timestamps are generated by artificial intelligence, and are not 100% accurate depending on the platform used for listening.

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Today’s show is sponsored by:

Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SHOPIFY.COM/beginners⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to start selling with Shopify today.

Download the⁠⁠ ⁠⁠⁠⁠⁠⁠⁠Plynk app⁠⁠⁠⁠⁠⁠⁠⁠⁠ today to start building your investing confidence: https://plynkinvest.app.link/IFB ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Go to ⁠auraframes.com⁠ and use promo code BEGINNERS at checkout to get $35 off

Get your free quote and see how much you could save at ⁠SelectQuote.com/beginners⁠

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Interested in how your company sponsor the show? Reach us at  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠equity@einvestingforbeginners.com

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SUBSCRIBE TO THE SHOW ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tunein
Learn more about your ad choices. Visit megaphone.fm/adchoices

More from The Investing for Beginners Podcast - Your Path to Financial Freedom

All 196 episodes
Emerging Moats, Oscar Health, and Kraken Robotics – with Brett SchaeferThe Investing for Beginners Podcast - Your Path to Financial Freedom · 1 h 8 min
Listen in VO